PMTV Q1 2026 Earnings Persistent Headwinds Trigger Significant EPS Miss DFTX Q1 2026 Earnings EPS Misses Estimates by 4143 as PreRevenue Biotech Reports Wider Loss Cytokinetics Q1 2026 Earnings Narrower Loss Beats Estimates as Lead Program Aficamten Advances Axsome Therapeutics Q1 2026 Earnings WiderThanExpected Loss as Pipeline Progress Takes Center Stage BORR Q1 2026 Earnings Earnings Misses Estimates as Loss Widens GPN Q1 2026 Earnings EPS Beats Estimates by 366 as Stock Edges Higher